Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Therapy for ventilator-associated pneumonia.

A B Carter1, D B Hornick

  • 1Division of Pulmonary, Critical Care, and Occupational Medicine, University of Iowa College of Medicine, Iowa City, USA.

Clinics in Chest Medicine
|October 12, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vegetative fragment production as a means of propagule dispersal for tropical seagrass meadows.

Marine environmental research·2023
Same author

Reproductive benefits of no-take marine reserves vary with region for an exploited coral reef fish.

Scientific reports·2017
Same author

Spatial variation in the effects of size and age on reproductive dynamics of common coral trout Plectropomus leopardus.

Journal of fish biology·2014
Same author

Some observations on liver function tests in diseases not primarily hepatic.

British medical journal·2010
Same author

Anorexia nervosa.

Proceedings of the Royal Society of Medicine·2010
Same author

Increased accuracy of batch fecundity estimates using oocyte stage ratios in Plectropomus leopardus.

Journal of fish biology·2010
Same journal

Pneumonia Reimagined: Host, Microbe, and the Shifting Landscape of Disease.

Clinics in chest medicine·2026
Same journal

Advocacy in Pneumonia.

Clinics in chest medicine·2026
Same journal

Vaccines Against Pneumonia: Current Updates.

Clinics in chest medicine·2026
Same journal

Non-antibiotic Treatments for Pneumonia: Host-Directed Therapies, Next-Steps and Future Directions.

Clinics in chest medicine·2026
Same journal

Customizing Antibiotic Treatment for Pneumonia: Can We Have a Single Unified Algorithm for All Types of Pneumonia?

Clinics in chest medicine·2026
Same journal

The Role of Complex Digital Interventions to Improve Pneumonia Care.

Clinics in chest medicine·2026
See all related articles

Ventilator-associated pneumonia (VAP) is a severe risk for patients on mechanical ventilation. This review covers prevention strategies, organism differences in early vs. late VAP, and antibiotic selection considerations.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Pneumonia is a significant risk for patients requiring mechanical ventilation.
  • Ventilator-associated pneumonia (VAP) remains a challenge despite preventive measures.
  • Effective management requires understanding causative organisms and appropriate antibiotic therapy.

Purpose of the Study:

  • To review current strategies for preventing ventilator-associated pneumonia.
  • To differentiate between early-onset and late-onset VAP.
  • To guide empiric antibiotic selection based on VAP classification and resistance patterns.

Main Methods:

  • Review of existing literature on VAP prevention and treatment.
  • Categorization of VAP into early (≤4 days) and late (>4 days) onset.

Related Experiment Videos

  • Analysis of common pathogens and recommended empiric antibiotic choices for each category.

    • Main Results:

    • Early-onset VAP is often caused by antibiotic-sensitive organisms, while late-onset VAP is more frequently associated with resistant pathogens.
    • Empiric antibiotic selection should consider local resistance patterns, pharmacodynamics, and drug penetration.
    • Adjustments to antibiotic therapy are crucial once the causative agent is identified.

    Conclusions:

    • Stratifying VAP into early and late onset aids in optimizing antibiotic selection.
    • A thorough understanding of microbial epidemiology and antibiotic properties is essential for effective VAP treatment.
    • Tailoring antibiotic therapy based on VAP onset and identified pathogens improves patient outcomes.